Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Cancer Research

• Publication date

  1997-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9102202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumour biological features of BRCA1-induced breast and ovarian cancer.

  1997cited by this paper
• Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

  1996cited by this paper
• Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.

  1996cited by this paper
• A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

  1996cited by this paper
• Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

  1996cited by this paper
• High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.

  1996cited by this paper
• Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.

  1996cited by this paper
• Induction of apoptosis by the tumor suppressor protein BRCA1.

  1996cited by this paper
• Genetic alterations in breast cancer

  1995cited by this paper
• Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.

  1995cited by this paper
• Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.

  1995cited by this paper
• Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.

  1995cited by this paper
• Computer image analysis of comparative genomic hybridization.

  1995cited by this paper
• High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium.

  1995cited by this paper
• Inherited breast and ovarian cancer.

  1995cited by this paper
• Genes, chromosomes & cancer

  1995cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

  1994cited by this paper
• Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes.

  1994cited by this paper
• Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer

  1994cited by this paper
• Inactivation of both APC alleles in human and mouse tumors.

  1994cited by this paper
• Somatic genetic changes in human breast cancer.

  1994cited by this paper
• Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.

  1994cited by this paper
• Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples.

  1994cited by this paper
• Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.

  1994cited by this paper
• Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

  1994cited by this paper
• Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer.

  1993cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper
• Antioncogenes and human cancer.

  1993cited by this paper
• Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

  1992cited by this paper
• Genetic Epidemiology of Cancer

  1989cited by this paper
• Chromosomal deletion and retinoblastoma.

  1976cited by this paper

• Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations

  2024cites this paper
• A Review of PARP-1 Inhibitors: Assessing Emerging Prospects and Tailoring Therapeutic Strategies

  2023cites this paper
• Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism

  2022cites this paper
• Exceptional behavior of breast cancer-associated type 1 gene in breast invasive carcinoma

  2022cites this paper
• Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing

  2021cites this paper
• Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer

  2021cites this paper
• Identification of regulatory crosstalks between RKIP and BRCA1 tumor suppressors in healthy tissues and cancer (breast and ovarian): Therapeutic implications

  2020cites this paper
• Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays

  2020cites this paper
• Interplay between BRCA1 and GADD45A and Its Potential for Nucleotide Excision Repair in Breast Cancer Pathogenesis

  2020cites this paper
• Prediction of -association in hereditary non- breast carcinomas with array-CGH

  2020cites this paper
• Ataxia–telangiectasia mutated coordinates the ovarian DNA repair and atresia-initiating response to phosphoramide mustard†

  2019cites this paper
• Development and implementation of precision therapies targeting base-excision DNA repair in BRCA1-associated tumors

  2019cites this paper
• Olaparib in germline-mutated metastatic breast cancer: implications of the OlympiAD trial.

  2019cites this paper
• Genetic ablation of mammary ducts through foxa1 prevents breast cancer occurrence.

  2019cites this paper
• Adjuvant Systemic Chemotherapy for HER2-Negative Disease

  2019cites this paper
• TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells

  2019cites this paper
• Protein interaction disruption in cancer

  2019cites this paper
• Expression differences between proteins responsible for DNA damage repair according to the Gleason grade as a new heterogeneity marker in prostate cancer

  2019cites this paper
• Deciphering the ovarian proteomic impacts of obesity

  2019cites this paper
• Hereditary Risk for Cancer

  2019cites this paper
• PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer

  2018cites this paper
• ATM-dependent activation of SIM2s regulates homologous recombination and epithelial-mesenchymal transition

  2018cites this paper
• BRCA 1 185 delAG tumors may acquire therapy resistance through expression of RINGless BRCA 1

  2018cites this paper
• PHOPSPHORYLATION AND UBIQUITIN MODIFICATION AT DNA DAMAGE SITES IN RESPONSE TO DOUBLE-STRAND BREAKS

  2017cites this paper
• In silico-Based Virtual Drug Screening and Molecular Docking Analysis of Phyto Chemical Derived Compounds and FDA Approved Drugs against BRCA1 Receptor

  2017cites this paper
• Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer

  2017cites this paper
• Residual breast cancer metabolic phenotype after docetaxel treatment

  2016cites this paper
• BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.

  2016cites this paper
• Unsolved mystery: the role of BRCA1 in DNA end-joining

  2016cites this paper
• The identification of novel strategies for the prevention and treatment of breast cancer in BRCA1-mutation carriers

  2016cites this paper
• Proper genomic profiling of (BRCA1‐mutated) basal‐like breast carcinomas requires prior removal of tumor infiltrating lymphocytes

  2015cites this paper
• Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.

  2015cites this paper
• Robust BRCA1‐like classification of copy number profiles of samples repeated across different datasets and platforms

  2015cites this paper
• Impaired DNA Repair as a Mechanism for Oocyte Aging: Is It Epigenetically Determined?

  2015cites this paper
• Mitomycin C sensitivity and chromosomal alterations in BRCA2 mutated cells

  2015cites this paper
• INVESTIGATION OF GENETIC ALTERATIONS IN EMT SUPPRESSOR, DEAR1, THROUGH PAN-CANCER ANALYSIS AND ULTRA-DEEP TARGETED SEQUENCING IN DUCTAL CARCINOMA IN SITU

  2015cites this paper
• Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications

  2015cites this paper
• Considerations for Comprehensive Assessment of Genetic Predisposition in Familial Breast Cancer

  2015cites this paper
• Effect of aflatoxin B1 on BRCA1 and BRCA2 genes expression under in vitro cultured cell line of normal Human Mammary Epithelial Cells (HMEC)

  2015cites this paper
• Mutations at BRCAJ: The Medullary Breast Carcinoma Revisited1

  2015cites this paper
• ANALYSIS OF THE ROLE OF TRF1 PHOSPHORYLATION AND TRF1 DOMAIN STRUCTURE IN ALTERNATIVE LENGTHENING OF TELOMERES ACTIVITY

  2015cites this paper
• CONSEQUENCES OF BRCA1 EPIGENETIC SILENCING ON HOMOLOGOUS RECOMBINATION AND DISEASE PROGRESSION IN MYELOID NEOPLASMS

  2015cites this paper
• Genomic profiling of CHEK2*1100delC-mutated breast carcinomas

  2015cites this paper
• Genome instability in blood cells of a BRCA1+ breast cancer family

  2014cites this paper
• Association between BRCA1 rs799917 polymorphism and breast cancer risk: A meta-analysis of 19,878 subjects.

  2014cites this paper
• Correlation between gene expression and mutator phenotype predicts homologous recombination deficiency and outcome in ovarian cancer

  2014cites this paper
• Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

  2014cites this paper
• Circulating levels and clinical implications of epithelial membrane antigen and cytokeratin-1 in women with breast cancer: can their ratio improve the results?

  2014cites this paper
• Molecular Detection of Hereditary Breast Cancer Susceptibility Genes (BRCA1 / BRCA2) in Palestine

  2014cites this paper
• Loss of BRCA1 impairs centromeric cohesion and triggers chromosomal instability

  2014cites this paper
• Tumour Suppressor Mechanisms in the Control of Chromosome Stability: Insights from BRCA2

  2014cites this paper
• Targeting the BRCA1/2 tumor suppressors.

  2014cites this paper
• Medullary breast carcinoma in an 18‐year‐old female: Report on one case diagnosed on fine‐needle cytology sample

  2014cites this paper
• Breast Cancers with a BRCA1-like DNA Copy Number Profile Recur Less Often Than Expected after High-Dose Alkylating Chemotherapy

  2014cites this paper
• ANALISIS DE MUTACIONES EN EL GEN BRCA1 EN MUJERES CON CANCER DE MAMA HEREDOFAMILIAR ATENDIDAS EN LOS SERVICIOS DE ONCOLOGIA DE BUCARAMANGA

  2013cites this paper
• Brca 2 is involved in meiosis in Arabidopsis thaliana as suggested by its interaction with Dmc 1

  2013cites this paper
• HIF-1α Overexpression in Ductal Carcinoma In Situ of the Breast in BRCA1 and BRCA2 Mutation Carriers

  2013cites this paper
• Causes of genome instability.

  2013cites this paper
• The Gene Desert Mammary Carcinoma Susceptibility Locus Mcs1a Regulates Nr2f1 Modifying Mammary Epithelial Cell Differentiation and Proliferation

  2013cites this paper
• Molecular Mechanism and Targeted Therapy Options of Triple-Negative (ER, PgR, HER-2/neu) Breast Cancer: Review

  2013cites this paper
• Exome Sequencing of Germline DNA from Non-BRCA1/2 Familial Breast Cancer Cases Selected on the Basis of aCGH Tumor Profiling

  2013cites this paper
• The complex genetic landscape of familial breast cancer

  2013cites this paper
• BRCA1 in the DNA damage response and at telomeres

  2013cites this paper
• Expression profiling of brca1 gene in familial breast cancer in India

  2012cites this paper
• Prediction of "BRCAness" in breast cancer by array comparative genomic hybridization

  2012cites this paper
• Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations

  2012cites this paper
• Mechanistic Investigation of Tolfenamic Acid, Betulinic Acid, and Aspirin in Anti-Cancer Therapy

  2012cites this paper
• Dysfunctional telomeres in human BRCA2 mutated breast tumors and cell lines.

  2012cites this paper
• Somatic Mutations in Breast Cancer Genomes : Discovery and Validation of Breast Cancer Genes

  2012cites this paper
• A New Pathway Responsible For 53BP1 Loss in Breast Cancer and Laminopathies

  2012cites this paper
• Genomic analysis: toward a new approach in breast cancer management.

  2012influential citation
• Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH

  2012cites this paper
• Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation.

  2012cites this paper
• Tetraploidy in BRCA2 breast tumours.

  2012cites this paper
• Molecular and Cellular Pathobiology The Retinoblastoma Gene Undergoes Rearrangements in BRCA 1-De fi cient Basal-like Breast Cancer

  2012cites this paper
• Integrated Systems and Technologies Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA 1 / 2 Inactivation

  2012cites this paper
• Rol de BRCA1 en la regulación de la transcripción en cáncer de próstata

  2011cites this paper
• Genomic signature of BRCA1 deficiency in sporadic basal‐like breast tumors

  2011cites this paper
• Molecular biomarkers associated with mutant BRCAl breast cancer patients

  2011cites this paper
• A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogen.

  2011influential citation
• The Changing Role of Pathology in Breast Cancer Diagnosis and Treatment

  2011cites this paper
• Therapeutic potential of PARP inhibitors for metastatic breast cancer

  2011cites this paper
• MAD2L1 (mitotic arrest deficient 2, yeast, human homolog like-1)

  2011cites this paper
• Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73

  2011cites this paper
• Pathology of hereditary breast cancer

  2011cites this paper
• Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy.

  2011cites this paper
• Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1

  2011cites this paper
• The Significance of PITX2 Overexpression in Human Colorectal Cancer

  2011cites this paper
• Inherited mutations impair responses to environmental carcinogens : Cancer prevention in mutation carriers

  2011influential citation
• Preventing hereditary cancers caused by opportunistic carcinogens

  2011cites this paper
• Human BRCA1-Associated Breast Cancer: No Increase in Numerical Chromosomal Instability Compared to Sporadic Tumors

  2011cites this paper
• The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer

  2011cites this paper
• Ovarialkarzinom: alte Probleme und neue Lösungsansätze

  2011cites this paper
• RETRACTED: Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells

  2011cites this paper
• Regulatory mechanisms governing mammary epithelial and progenitor cell growth

  2011cites this paper
• BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

  2011cites this paper
• Pathology of hereditary breast cancer

  2011cites this paper
• Genomic alterations in histopathologically normal breast tissue from BRCA1 mutation carriers may be caused by BRCA1 haploinsufficiency

  2010cites this paper